JP2007519633A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007519633A5 JP2007519633A5 JP2006547521A JP2006547521A JP2007519633A5 JP 2007519633 A5 JP2007519633 A5 JP 2007519633A5 JP 2006547521 A JP2006547521 A JP 2006547521A JP 2006547521 A JP2006547521 A JP 2006547521A JP 2007519633 A5 JP2007519633 A5 JP 2007519633A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- substituted
- hydroxy
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 98
- 150000001875 compounds Chemical class 0.000 claims 67
- 150000003839 salts Chemical class 0.000 claims 32
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 31
- 235000019000 fluorine Nutrition 0.000 claims 28
- 125000001424 substituent group Chemical group 0.000 claims 28
- 239000001257 hydrogen Substances 0.000 claims 24
- 229910052739 hydrogen Inorganic materials 0.000 claims 24
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 24
- 125000005843 halogen group Chemical group 0.000 claims 21
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 19
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 17
- 229910052731 fluorine Inorganic materials 0.000 claims 17
- 239000011737 fluorine Substances 0.000 claims 17
- 150000002431 hydrogen Chemical class 0.000 claims 17
- 125000001153 fluoro group Chemical group F* 0.000 claims 11
- 125000003545 alkoxy group Chemical group 0.000 claims 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 9
- 125000000623 heterocyclic group Chemical group 0.000 claims 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 6
- 229910052794 bromium Inorganic materials 0.000 claims 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 5
- 239000001301 oxygen Substances 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- -1 -COR 11 Chemical group 0.000 claims 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 3
- 239000000460 chlorine Substances 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- JVYMKTAPCLSXLC-UHFFFAOYSA-N COClO Chemical compound COClO JVYMKTAPCLSXLC-UHFFFAOYSA-N 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000005647 linker group Chemical group 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 102000009410 Chemokine receptor Human genes 0.000 claims 1
- 108050000299 Chemokine receptor Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 125000002837 carbocyclic group Chemical group 0.000 claims 1
- ONCCWDRMOZMNSM-FBCQKBJTSA-N compound Z Chemical compound N1=C2C(=O)NC(N)=NC2=NC=C1C(=O)[C@H]1OP(O)(=O)OC[C@H]1O ONCCWDRMOZMNSM-FBCQKBJTSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- AQYSYJUIMQTRMV-UHFFFAOYSA-N hypofluorous acid Chemical compound FO AQYSYJUIMQTRMV-UHFFFAOYSA-N 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- RLMUBIZOFHUHBI-UHFFFAOYSA-N trifluoromethyl hypochlorite Chemical compound FC(F)(F)OCl RLMUBIZOFHUHBI-UHFFFAOYSA-N 0.000 claims 1
- 0 *C(CN(C1)C(C(*)(CC2)CC2N*)=O)c2c1cc(*)c*2* Chemical compound *C(CN(C1)C(C(*)(CC2)CC2N*)=O)c2c1cc(*)c*2* 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53389204P | 2004-01-02 | 2004-01-02 | |
| PCT/US2004/043777 WO2005067502A2 (en) | 2004-01-02 | 2004-12-29 | Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007519633A JP2007519633A (ja) | 2007-07-19 |
| JP2007519633A5 true JP2007519633A5 (enExample) | 2008-02-21 |
Family
ID=34794243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006547521A Withdrawn JP2007519633A (ja) | 2004-01-02 | 2004-12-29 | アルキルアミノ、アリールアミノおよびスルホンアミドシクロペンチルアミド系のケモカイン受容体活性調節剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070117797A1 (enExample) |
| EP (1) | EP1701724A4 (enExample) |
| JP (1) | JP2007519633A (enExample) |
| CN (1) | CN1897941A (enExample) |
| AU (1) | AU2004313486A1 (enExample) |
| CA (1) | CA2551869A1 (enExample) |
| WO (1) | WO2005067502A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004050024A2 (en) | 2002-11-27 | 2004-06-17 | Incyte Corporation | 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| CA2550596C (en) | 2003-12-18 | 2011-03-15 | Incyte Corporation | 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| CN1950085A (zh) | 2004-05-11 | 2007-04-18 | 因赛特公司 | 作为趋化因子受体调节剂的3－(4－杂芳基环己基氨基)环戊烷羧酰胺 |
| AP2006003849A0 (en) | 2004-06-28 | 2006-12-31 | Incyte Corp | 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors |
| AU2005259983B2 (en) | 2004-06-28 | 2011-07-28 | Incyte Corporation | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| MEP1008A (xx) | 2005-12-21 | 2010-02-10 | Incyte Corp | 3-aminociklopentankarboksamidi kao modulatori receptora hemokina |
| MX2009010828A (es) | 2007-04-06 | 2009-10-29 | Neurocrine Biosciences Inc | Antagonistas del receptor de la hormona liberadora de gonadotropina y metodos relacionados con los mismos. |
| CL2008000986A1 (es) * | 2007-04-06 | 2008-10-17 | Neurocrine Biosciences Inc | COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV |
| CA2706076A1 (en) * | 2007-11-23 | 2009-05-28 | Leo Pharma A/S | Novel cyclic hydrocarbon compounds for the treatment of diseases |
| AR080375A1 (es) | 2010-03-05 | 2012-04-04 | Sanofi Aventis | Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida |
| RU2726206C2 (ru) | 2015-05-21 | 2020-07-09 | Кемосентрикс, Инк. | Модуляторы ccr2 |
| EP3687525B1 (en) | 2017-09-25 | 2025-10-29 | ChemoCentryx, Inc. | Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitor |
| US20190269664A1 (en) | 2018-01-08 | 2019-09-05 | Chemocentryx, Inc. | Methods of treating solid tumors with ccr2 antagonists |
| CN112105353B (zh) | 2018-01-08 | 2024-04-19 | 凯莫森特里克斯股份有限公司 | Ccr2拮抗剂治疗实体瘤的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2369357A (en) * | 2000-10-09 | 2002-05-29 | Bayer Ag | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
| US20030204085A1 (en) * | 2001-02-02 | 2003-10-30 | Taveras Arthur G. | 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists |
| CA2483843A1 (en) * | 2002-04-29 | 2003-11-13 | Merck & Co. Inc. | Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| MY129850A (en) * | 2002-04-29 | 2007-05-31 | Merck Sharp & Dohme | Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| JP3780291B2 (ja) * | 2002-04-29 | 2006-05-31 | メルク エンド カムパニー インコーポレーテッド | テトラヒドロピラニルシクロペンチルテトラヒドロピリドピリジン系のケモカイン受容体活性調節剤 |
| AU2003286701B2 (en) * | 2002-10-30 | 2008-12-18 | Merck Sharp & Dohme Corp. | Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| WO2004110376A2 (en) * | 2003-06-06 | 2004-12-23 | Merck & Co., Inc. | Ccr-2 antagonists for treatment of neuropathic pain |
| US7557124B2 (en) * | 2004-04-26 | 2009-07-07 | Merck & Co., Inc. | Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
-
2004
- 2004-12-29 JP JP2006547521A patent/JP2007519633A/ja not_active Withdrawn
- 2004-12-29 CA CA002551869A patent/CA2551869A1/en not_active Abandoned
- 2004-12-29 WO PCT/US2004/043777 patent/WO2005067502A2/en not_active Ceased
- 2004-12-29 US US10/585,232 patent/US20070117797A1/en not_active Abandoned
- 2004-12-29 CN CNA200480038562XA patent/CN1897941A/zh active Pending
- 2004-12-29 EP EP04815779A patent/EP1701724A4/en not_active Withdrawn
- 2004-12-29 AU AU2004313486A patent/AU2004313486A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006514003A5 (enExample) | ||
| JP2011519865A5 (enExample) | ||
| JP2011500544A5 (enExample) | ||
| JP2005531607A5 (enExample) | ||
| CA2440037A1 (en) | Benzimidazole derivatives for modulating the rage receptor | |
| JP2010513447A5 (enExample) | ||
| JP2012521428A5 (enExample) | ||
| CA2889892A1 (en) | Alternative uses for hbv assembly effectors | |
| CA2693180A1 (en) | Fused bicyclic compound | |
| RU2012138709A (ru) | Производные арилметокси изоиндолина и композиции, включающие их, и способы их применения | |
| JP2015536973A (ja) | ＰＤＥ４阻害剤とＰＩ３δ阻害剤または二重ＰＩ３δ−γキナーゼ阻害剤とを含有する薬学的組成物 | |
| JP2006513265A5 (enExample) | ||
| JP2009521483A5 (enExample) | ||
| RU2002129564A (ru) | Макроциклические ингибиторы сериновой ns3-протеазы, включающие n-циклические р2 структурные элементы вируса гепатита с | |
| JP2009524676A5 (enExample) | ||
| JP2011500545A5 (enExample) | ||
| JP2006520783A5 (enExample) | ||
| JP2010155827A5 (enExample) | ||
| RU2012110380A (ru) | Новое производное 5-фторурацила | |
| JP2010505865A5 (enExample) | ||
| JP5609643B2 (ja) | 慢性腎不全処置剤 | |
| JP2003519228A5 (enExample) | ||
| JP2007518799A5 (enExample) | ||
| RU2005137571A (ru) | Новые производные диазабициклононена | |
| CA2617817A1 (en) | Thiazole derivatives for treating or preventing sleep disorders |